| Peer-Reviewed

Incidence and Factors of Hypoglycemia in Perioperative Patients with Type 2 Diabetes Mellitus on Insulin Pump Therapy

Received: 16 February 2021    Accepted: 13 March 2021    Published: 26 March 2021
Views:       Downloads:
Abstract

Objective: To estimate the incidence of and identified factors associated with hypoglycemia among perioperative diabetes patients with insulin pump therapy. Methods: This was a retrospective cohort study of type 2 diabetes patients with insulin pump therapy newly received surgery. All patients were divided into hypoglycemia group and non-hypoglycemia group according to whether they experienced hypoglycemia. Information about clinical characteristics and treatments were collected and compared between two groups. We estimated the incidence of hypoglycemia, and identified factors associated with hypoglycemia by using multivariable logistic regression. Results: A total of 172 episodes of hypoglycemia were observed in 88 (39.8%) patients, among which, 146 (84.9%) were level 1 hypoglycemia (<3.9 mmol/L) and 26 (15.1%) were level 2 (< 3.0 mmol/L). No severe hypoglycemia (level 3) was reported in this study. Results from the multivariable logistic regression model found that diabetes patients with a longer duration of pump use were more likely to have hypoglycemia (AOR=1.09 with 95% CI=1.04-1.15). However, those diabetes patients who were with higher BMI and eGFR were less likely to have hypoglycemia (AOR=0.86 with 95% CI=0.76-0.98; AOR=0.86 with 95% CI=0.76-0.98, respectively). Conclusion: Perioperative diabetes patients with insulin pump therapy were prone to develop mild to moderate hypoglycemia. The long-term of receiving insulin pump therapy during the perioperative period, with lower BMI and eGFR, put type 2 diabetes at higher risks in hypoglycemia. It may help healthcare providers to screen hypoglycemia among type 2 diabetes patients with receiving long-term insulin pump therapy.

Published in American Journal of Nursing Science (Volume 10, Issue 2)
DOI 10.11648/j.ajns.20211002.13
Page(s) 128-132
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Continuous Subcutaneous Insulin Infusion, Insulin Pump Therapy, Perioperative Period, Type 2 Diabetes Mellitus, Hypoglycemia

References
[1] Boyle ME, Seifert KM, Beer KA, Apsey HA, Nassar AA, Littman SD, et al. Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. Journal of diabetes science and technology. 2012; 6 (1): 184-190.
[2] Mu Y, Yin S, Chinese Medical Practitioners Association, Endocrinology and Metabolism Branch, Chinese Society of Endocrinology, Chinese Diabetes Society. Insulin pump therapy guidelines for China (July 2010). Journal of diabetes. 2012; 4 (2): 127-139.
[3] Leung V, Ragbir-Toolsie K. Perioperative management of patients with diabetes. Health services insights. 2017; 10: 1-5.
[4] Kotagal M, Symons RG, Hirsch IB, Umpierrez GE, Dellinger EP, Farrokhi ET, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Annals of surgery. 2015; 261 (1): 97-103.
[5] Reis J, Pignatelli D, Madeira D, Castedo JL, de Oliveira MC. Subcutaneous insulin pump therapy in a diabetic patient submitted to major surgery. Postgraduate medical journal. 1988; 64 (750): 335-338.
[6] White W, Montalvo H, Monday JM. Continuous subcutaneous insulin infusion during general anesthesia: a case report. AANA journal. 2004; 72 (5): 353-358.
[7] Angelini G, Ketzler J, Coursin D. Perioperative care of the diabetic patient. ASA Refresher Courses in Anesthesiology. 2001; 29 (1): 1-9.
[8] Zacharias A, Habib RH. Factors predisposing to median sternotomy complications: deep vs superficial infection. Chest. 1996; 110 (5): 1173-1178.
[9] Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes care. 2009; 32 (7): 1153-1157.
[10] Association AD. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005; 28 (5): 1245-1249.
[11] Anthony M. Treatment of hypoglycemia in hospitalized adults. The Diabetes Educator. 2007; 33 (4): 709-715.
[12] Arias P, Kerner W, Zier H, Navascués I, Pfeiffer EF. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care. 1985; 8 (2): 134-140.
[13] Yue X, Wu J, Ruan Z, Wolden ML, Li L, Lin Y. The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals. Value in health regional issues. 2020; 21: 17-21.
[14] Quilliam BJ, Simeone JC, Ozbay AB. Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case–control study. Clinical therapeutics. 2011; 33 (11): 1781-1791.
[15] Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes care. 2005; 28 (12): 2948-2961.
[16] Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. Bmj. 2010; 340: b5444-5456.
[17] Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. New England Journal of Medicine. 2010; 363 (15): 1410-1418.
[18] Group UHS. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007; 50 (6): 1140-1147.
[19] Koye D, Shaw J, Reid C, Atkins RC, Reutens AT, Magliano DJ. Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. Diabetic Medicine. 2017; 34 (7): 887-901.
[20] Liu L, Ke W, Wan X, Zhang P, Cao X, Deng W, et al. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission. Diabetes research and clinical practice. 2015; 108 (2): 250-257.
[21] Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabetic medicine. 2006; 23 (7): 750-756.
[22] Henderson J, Allen K, Deary I, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabetic Medicine. 2003; 20 (12): 1016-1021.
Cite This Article
  • APA Style

    Xiaohua Lu, Youshuang Zhu, Wane Zhao, Yan Liu, Xixi Luo, et al. (2021). Incidence and Factors of Hypoglycemia in Perioperative Patients with Type 2 Diabetes Mellitus on Insulin Pump Therapy. American Journal of Nursing Science, 10(2), 128-132. https://doi.org/10.11648/j.ajns.20211002.13

    Copy | Download

    ACS Style

    Xiaohua Lu; Youshuang Zhu; Wane Zhao; Yan Liu; Xixi Luo, et al. Incidence and Factors of Hypoglycemia in Perioperative Patients with Type 2 Diabetes Mellitus on Insulin Pump Therapy. Am. J. Nurs. Sci. 2021, 10(2), 128-132. doi: 10.11648/j.ajns.20211002.13

    Copy | Download

    AMA Style

    Xiaohua Lu, Youshuang Zhu, Wane Zhao, Yan Liu, Xixi Luo, et al. Incidence and Factors of Hypoglycemia in Perioperative Patients with Type 2 Diabetes Mellitus on Insulin Pump Therapy. Am J Nurs Sci. 2021;10(2):128-132. doi: 10.11648/j.ajns.20211002.13

    Copy | Download

  • @article{10.11648/j.ajns.20211002.13,
      author = {Xiaohua Lu and Youshuang Zhu and Wane Zhao and Yan Liu and Xixi Luo and Yan Zhou},
      title = {Incidence and Factors of Hypoglycemia in Perioperative Patients with Type 2 Diabetes Mellitus on Insulin Pump Therapy},
      journal = {American Journal of Nursing Science},
      volume = {10},
      number = {2},
      pages = {128-132},
      doi = {10.11648/j.ajns.20211002.13},
      url = {https://doi.org/10.11648/j.ajns.20211002.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajns.20211002.13},
      abstract = {Objective: To estimate the incidence of and identified factors associated with hypoglycemia among perioperative diabetes patients with insulin pump therapy. Methods: This was a retrospective cohort study of type 2 diabetes patients with insulin pump therapy newly received surgery. All patients were divided into hypoglycemia group and non-hypoglycemia group according to whether they experienced hypoglycemia. Information about clinical characteristics and treatments were collected and compared between two groups. We estimated the incidence of hypoglycemia, and identified factors associated with hypoglycemia by using multivariable logistic regression. Results: A total of 172 episodes of hypoglycemia were observed in 88 (39.8%) patients, among which, 146 (84.9%) were level 1 hypoglycemia (Conclusion: Perioperative diabetes patients with insulin pump therapy were prone to develop mild to moderate hypoglycemia. The long-term of receiving insulin pump therapy during the perioperative period, with lower BMI and eGFR, put type 2 diabetes at higher risks in hypoglycemia. It may help healthcare providers to screen hypoglycemia among type 2 diabetes patients with receiving long-term insulin pump therapy.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Incidence and Factors of Hypoglycemia in Perioperative Patients with Type 2 Diabetes Mellitus on Insulin Pump Therapy
    AU  - Xiaohua Lu
    AU  - Youshuang Zhu
    AU  - Wane Zhao
    AU  - Yan Liu
    AU  - Xixi Luo
    AU  - Yan Zhou
    Y1  - 2021/03/26
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ajns.20211002.13
    DO  - 10.11648/j.ajns.20211002.13
    T2  - American Journal of Nursing Science
    JF  - American Journal of Nursing Science
    JO  - American Journal of Nursing Science
    SP  - 128
    EP  - 132
    PB  - Science Publishing Group
    SN  - 2328-5753
    UR  - https://doi.org/10.11648/j.ajns.20211002.13
    AB  - Objective: To estimate the incidence of and identified factors associated with hypoglycemia among perioperative diabetes patients with insulin pump therapy. Methods: This was a retrospective cohort study of type 2 diabetes patients with insulin pump therapy newly received surgery. All patients were divided into hypoglycemia group and non-hypoglycemia group according to whether they experienced hypoglycemia. Information about clinical characteristics and treatments were collected and compared between two groups. We estimated the incidence of hypoglycemia, and identified factors associated with hypoglycemia by using multivariable logistic regression. Results: A total of 172 episodes of hypoglycemia were observed in 88 (39.8%) patients, among which, 146 (84.9%) were level 1 hypoglycemia (Conclusion: Perioperative diabetes patients with insulin pump therapy were prone to develop mild to moderate hypoglycemia. The long-term of receiving insulin pump therapy during the perioperative period, with lower BMI and eGFR, put type 2 diabetes at higher risks in hypoglycemia. It may help healthcare providers to screen hypoglycemia among type 2 diabetes patients with receiving long-term insulin pump therapy.
    VL  - 10
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Endocrinology, First Affiliated Hospital of Jinan University, Guangzhou, China

  • Department of Burn and Plastic Surgery and Intervention, First Affiliated Hospital of Jinan University, Guangzhou, China

  • Department of Endocrinology, First Affiliated Hospital of Jinan University, Guangzhou, China

  • Department of Endocrinology, First Affiliated Hospital of Jinan University, Guangzhou, China

  • Department of Endocrinology, First Affiliated Hospital of Jinan University, Guangzhou, China

  • Department of Endocrinology, First Affiliated Hospital of Jinan University, Guangzhou, China

  • Sections